Spots Global Cancer Trial Database for unresectable pancreatic cancer
Every month we try and update this database with for unresectable pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer | NCT03585062 | Pancreatic Canc... Neoadjuvant Che... | S1, Paclitaxel-albu... | 18 Years - 80 Years | Zhejiang Provincial People's Hospital | |
| Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer | NCT00222469 | Metastatic Panc... | bevacizumab gemcitabine oxaliplatin | 18 Years - | University of Oklahoma | |
| A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma | NCT03250273 | Metastatic Chol... Cholangiocarcin... Pancreatic Canc... Metastatic Panc... Unresectable Pa... Unresectable Ch... | Entinostat Nivolumab Entinostat Nivolumab | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options | NCT03602885 | Metastatic Panc... Unresectable Pa... Metastatic Colo... | Usual chemother... Chemotherapy ed... | 21 Years - | Dana-Farber Cancer Institute | |
| A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer | NCT05657743 | Pancreatic Canc... Unresectable Pa... Metastatic Panc... Pancreatic Aden... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer | NCT05251038 | Pancreatic Canc... Unresectable Pa... Metastatic Panc... KRAS P.G12C | Sotorasib Liposomal Irino... 5 Fluorouracil ... Leucovorin (LV) Gemcitabine (GE... Nab paclitaxel | 18 Years - | Hoosier Cancer Research Network | |
| Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System | NCT02041936 | Unresectable Pa... | NanoKnife IRE S... | 18 Years - | University of Maryland, Baltimore | |
| NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer | NCT01369420 | Pancreatic Aden... | NanoKnife Low E... | 18 Years - | Angiodynamics, Inc. | |
| Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer | NCT06026943 | Pancreatic Canc... Unresectable Pa... Pancreatic Aden... | DaRT seeds inse... | 18 Years - 120 Years | Alpha Tau Medical LTD. | |
| EUS-RFA for Unresectable Pancreatic Cancer | NCT04310111 | Pancreatic Duct... | EUS-RFA | 20 Years - 80 Years | First People's Hospital of Hangzhou | |
| Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) | NCT01587534 | Pancreatic Canc... | Norzyme | 18 Years - | National Cancer Center, Korea | |
| Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System | NCT02041936 | Unresectable Pa... | NanoKnife IRE S... | 18 Years - | University of Maryland, Baltimore | |
| Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer | NCT01304160 | Pancreatic Canc... Unresectable Pa... | stereotactic bo... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options | NCT03602885 | Metastatic Panc... Unresectable Pa... Metastatic Colo... | Usual chemother... Chemotherapy ed... | 21 Years - | Dana-Farber Cancer Institute | |
| Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer | NCT04002479 | Pancreatic Canc... Unresectable Pa... Metastatic Panc... Pancreatic Aden... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899649 | Stage III Pancr... | SOC NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer | NCT02945267 | Unresectable Pa... | Nimotuzumab plu... Placebo plus S1 | 18 Years - 75 Years | Chinese PLA General Hospital | |
| Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma | NCT04270929 | Pancreatic Aden... | FOLFIRI FOLFIRINOX TriSalus Infusi... | 18 Years - 80 Years | Roger Williams Medical Center | |
| Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer. | NCT02035072 | Unresectable Pa... Nonmetastatic P... Locally Advance... | Gemcitabine Oxaliplatin Hypofractionate... | 18 Years - 75 Years | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer | NCT03627390 | Metastatic Panc... Unresectable Pa... | BP-C1 BP-C2 | 18 Years - 80 Years | Meabco A/S | |
| RFA RCT for Pancreatic or Bile Duct Cancer | NCT02166190 | Unresectable Pa... Cholangiocarcin... | Radiofrequency ... Stenting only | 18 Years - | Weill Medical College of Cornell University | |
| Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) | NCT06278454 | Unresectable Pa... | NRT6008 Injecti... | 18 Years - | Chengdu New Radiomedicine Technology Co. LTD. | |
| Bioinformation Therapy for Pancreatic Cancer | NCT03239184 | Unresectable Pa... | Cancer ablation Life informatio... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer | NCT04698915 | SBRT Borderline Rese... Unresectable Pa... | Drug GC4711 Placebo | 18 Years - | Galera Therapeutics, Inc. | |
| Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer | NCT03941093 | Pancreatic Canc... | Pamrevlumab + G... Placebo + Gemci... | 18 Years - | FibroGen | |
| A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer | NCT05657743 | Pancreatic Canc... Unresectable Pa... Metastatic Panc... Pancreatic Aden... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer | NCT03585062 | Pancreatic Canc... Neoadjuvant Che... | S1, Paclitaxel-albu... | 18 Years - 80 Years | Zhejiang Provincial People's Hospital | |
| 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer | NCT00346281 | Pancreatic Canc... | 32P BioSilicon | 18 Years - | pSiMedica Limited | |
| A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer | NCT00245362 | Metastatic Panc... Nonresectable P... | CG 8020 and CG ... | 18 Years - | Cell Genesys | |
| Doxil Topotecan Doublet Cancer Study | NCT00252889 | Small Cell Lung... Pancreatic Canc... Head and Neck C... Gastric Cancer Esophageal Canc... | Topotecan and p... | 18 Years - | Christiana Care Health Services | |
| Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients With Unresectable Pancreatic Cancer. | NCT03252808 | Pancreatic Canc... Pancreatic Canc... | TBI-1401(HF10) Gemcitabine Nab-paclitaxel TS-1 | 20 Years - | Takara Bio Inc. | |
| Bilateral Thoracoscopic Splanchnicectomy for Pain Relief in Patients With Unresectable Pancreatic Cancer | NCT03117556 | Unresectable Pa... | Bilateral Thora... | 18 Years - | University of Louisville | |
| Doxil Topotecan Doublet Cancer Study | NCT00252889 | Small Cell Lung... Pancreatic Canc... Head and Neck C... Gastric Cancer Esophageal Canc... | Topotecan and p... | 18 Years - | Christiana Care Health Services | |
| 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer | NCT00346281 | Pancreatic Canc... | 32P BioSilicon | 18 Years - | pSiMedica Limited | |
| Improving Informed Consent for Palliative Chemotherapy | NCT02282722 | Metastatic Colo... Metastatic Panc... Unresectable Pa... | Investigational... Usual, standard... | 21 Years - | Dana-Farber Cancer Institute | |
| FAZA PET/MRI Pancreas | NCT04395469 | Pancreatic Aden... Locally Advance... Unresectable Pa... | 18F-FAZA | 18 Years - | University Health Network, Toronto | |
| BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer | NCT03627390 | Metastatic Panc... Unresectable Pa... | BP-C1 BP-C2 | 18 Years - 80 Years | Meabco A/S | |
| Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer | NCT04789486 | Non-small Cell ... Advanced Pancre... Unresectable Pa... Ductal Adenocar... | AGuIX Radiotherapy | 18 Years - | Dana-Farber Cancer Institute | |
| Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer | NCT06026943 | Pancreatic Canc... Unresectable Pa... Pancreatic Aden... | DaRT seeds inse... | 18 Years - 120 Years | Alpha Tau Medical LTD. | |
| Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma | NCT04270929 | Pancreatic Aden... | FOLFIRI FOLFIRINOX TriSalus Infusi... | 18 Years - 80 Years | Roger Williams Medical Center | |
| A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899636 | Stage III Pancr... | Modified FOLFIR... NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer | NCT00222469 | Metastatic Panc... | bevacizumab gemcitabine oxaliplatin | 18 Years - | University of Oklahoma | |
| Regional Versus Systemic Chemotherapy in the Treatment of Unresectable Pancreatic Cancer | NCT01665625 | Unresectable Pa... | regional interv... | 18 Years - 80 Years | Air Force Military Medical University, China | |
| RFA RCT for Pancreatic or Bile Duct Cancer | NCT02166190 | Unresectable Pa... Cholangiocarcin... | Radiofrequency ... Stenting only | 18 Years - | Weill Medical College of Cornell University | |
| Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer | NCT06387368 | Pancreatic Canc... | Huaier Granule Capecitabine | 18 Years - | Health Science Center of Xi'an Jiaotong University | |
| A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899649 | Stage III Pancr... | SOC NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer | NCT01369420 | Pancreatic Aden... | NanoKnife Low E... | 18 Years - | Angiodynamics, Inc. | |
| Bioinformation Therapy for Pancreatic Cancer | NCT03239184 | Unresectable Pa... | Cancer ablation Life informatio... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma | NCT04270929 | Pancreatic Aden... | FOLFIRI FOLFIRINOX TriSalus Infusi... | 18 Years - 80 Years | Roger Williams Medical Center | |
| FAZA PET/MRI Pancreas | NCT04395469 | Pancreatic Aden... Locally Advance... Unresectable Pa... | 18F-FAZA | 18 Years - | University Health Network, Toronto | |
| Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer | NCT02945267 | Unresectable Pa... | Nimotuzumab plu... Placebo plus S1 | 18 Years - 75 Years | Chinese PLA General Hospital | |
| Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer | NCT05251038 | Pancreatic Canc... Unresectable Pa... Metastatic Panc... KRAS P.G12C | Sotorasib Liposomal Irino... 5 Fluorouracil ... Leucovorin (LV) Gemcitabine (GE... Nab paclitaxel | 18 Years - | Hoosier Cancer Research Network | |
| A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899636 | Stage III Pancr... | Modified FOLFIR... NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
| Pre-operative Treatment for Patients With Untreated Pancreatic Cancer | NCT03138720 | Resectable Panc... Unresectable Pa... Pancreatic Aden... Neoadjuvant Pan... | Paclitaxel Prot... | 18 Years - | HonorHealth Research Institute | |
| Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer | NCT02945267 | Unresectable Pa... | Nimotuzumab plu... Placebo plus S1 | 18 Years - 75 Years | Chinese PLA General Hospital | |
| Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer | NCT04789486 | Non-small Cell ... Advanced Pancre... Unresectable Pa... Ductal Adenocar... | AGuIX Radiotherapy | 18 Years - | Dana-Farber Cancer Institute | |
| Improving Informed Consent for Palliative Chemotherapy | NCT02282722 | Metastatic Colo... Metastatic Panc... Unresectable Pa... | Investigational... Usual, standard... | 21 Years - | Dana-Farber Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
